Oct 3 (Reuters) - Australia's competition watchdog on Tuesday said Australian Clinical Labs' (ACL) proposed acquisition of medical centre operator Healius (HLS) would require it to divest its approved collection centres (ACCs) in Australia's Northern Territory.
News: ACL Regulator asks Australian Clinical Labs to divest collection centres
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.83 |
Change
-0.040(1.39%) |
Mkt cap ! $555.7M | |||
| Open | High | Low | Value | Volume |
| $2.87 | $2.89 | $2.83 | $1.569M | 550.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 23208 | $2.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.85 | 11000 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| ACL (ASX) Chart |